ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.493
-0.037 (-7.00%)
At close: Jan 21, 2025, 4:00 PM
0.612
+0.119 (24.14%)
Pre-market: Jan 22, 2025, 6:05 AM EST
ImmunoPrecise Antibodies Cash Flow Statement
Financials in millions CAD. Fiscal year is May - April.
Millions CAD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 | 2019 - 2015 |
| Net Income | -27.9 | -27.18 | -26.56 | -16.71 | -7.34 | -4.95 | Upgrade
|
| Depreciation & Amortization | 5.43 | 5.5 | 5.2 | 3.77 | 2.06 | 1.71 | Upgrade
|
| Other Amortization | 0.27 | 0.24 | 1.48 | - | 1.66 | 1.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | 15.03 | 15.03 | 2.46 | 0.17 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.26 | -0 | -0.04 | -0.04 | - | -0.03 | Upgrade
|
| Stock-Based Compensation | 0.74 | 1.54 | 1.94 | 3.08 | 2.75 | 0.74 | Upgrade
|
| Other Operating Activities | -2.37 | -1.74 | -1.04 | -0.77 | 1.3 | 0.56 | Upgrade
|
| Change in Accounts Receivable | -0.67 | -0.24 | -0.54 | 0.25 | -0.05 | -1.71 | Upgrade
|
| Change in Inventory | 0.15 | -0.1 | -0.19 | -0.5 | -0.32 | -0.02 | Upgrade
|
| Change in Accounts Payable | 1.32 | 0.98 | -1.67 | 1.46 | 0.88 | 0.17 | Upgrade
|
| Change in Unearned Revenue | 0.1 | 0.37 | -0.08 | -0.01 | -0.25 | 0.75 | Upgrade
|
| Change in Income Taxes | - | - | - | - | - | -0.12 | Upgrade
|
| Change in Other Net Operating Assets | -0.1 | 1.36 | -0.81 | -0.62 | -1.28 | -0.19 | Upgrade
|
| Operating Cash Flow | -7.74 | -4.25 | -19.83 | -9.92 | -0.6 | -1.39 | Upgrade
|
| Capital Expenditures | -1.29 | -1.4 | -1.5 | -1.07 | -1.43 | -0.46 | Upgrade
|
| Cash Acquisitions | - | -0.15 | -0.59 | -3.69 | -1.03 | -1.01 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.19 | - | -0.11 | Upgrade
|
| Investment in Securities | - | 0.12 | 0.08 | - | - | - | Upgrade
|
| Other Investing Activities | -0.09 | -0.14 | 0.04 | -0.26 | - | - | Upgrade
|
| Investing Cash Flow | -1.38 | -1.56 | -1.97 | -5.21 | -2.46 | -1.58 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 2.2 | 0.6 | Upgrade
|
| Total Debt Issued | 4.06 | - | - | - | 2.2 | 0.6 | Upgrade
|
| Long-Term Debt Repaid | - | -1.34 | -1.34 | -0.96 | -2.97 | -0.92 | Upgrade
|
| Net Debt Issued (Repaid) | 2.63 | -1.34 | -1.34 | -0.96 | -0.77 | -0.32 | Upgrade
|
| Issuance of Common Stock | 3.87 | 2.36 | 0.72 | 3.85 | 44.15 | 0.49 | Upgrade
|
| Other Financing Activities | - | - | - | -0.01 | - | - | Upgrade
|
| Financing Cash Flow | 6.5 | 1.02 | -0.62 | 2.88 | 43.38 | 0.17 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.14 | -0.03 | 0.74 | 0.46 | -1.18 | -0.05 | Upgrade
|
| Net Cash Flow | -2.48 | -4.82 | -21.68 | -11.79 | 39.15 | -2.85 | Upgrade
|
| Free Cash Flow | -9.03 | -5.64 | -21.33 | -10.99 | -2.03 | -1.85 | Upgrade
|
| Free Cash Flow Margin | -37.53% | -23.02% | -103.21% | -56.74% | -11.32% | -13.18% | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.22 | -0.86 | -0.56 | -0.12 | -0.14 | Upgrade
|
| Cash Interest Paid | - | - | 0.26 | 0.04 | 0.12 | 0.3 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.59 | 1.19 | 1.1 | 0.24 | Upgrade
|
| Levered Free Cash Flow | -2.71 | -0.71 | -11.78 | -3.42 | -1.5 | -0.76 | Upgrade
|
| Unlevered Free Cash Flow | -2.63 | -0.69 | -11.78 | -3.37 | -1.1 | -0.32 | Upgrade
|
| Change in Net Working Capital | -1.5 | -2.24 | 3.2 | -1.5 | 1.98 | 1.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.